Castle Biosciences (CSTL) Treasury Shares (2020 - 2026)

Castle Biosciences has disclosed Treasury Shares across 7 years of filings, most recently posting $433784.0 for Q1 2026.

• Treasury Shares for Q1 2026 came in at $433784.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $433784.0 (changed N/A YoY), and the FY2025 annual result was $350144.0, down 89.05% from the prior year.
• Treasury Shares came in at $433784.0 for Q1 2026 at Castle Biosciences, up from $350144.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $3.9 million in Q3 2025 to a low of $196033.0 in Q4 2022.
• The 5-year median for Treasury Shares is $391964.0 (2025), against an average of $1.4 million.
• Across the five-year window, Treasury Shares surged 1530.45% in 2024 and slumped 89.05% in 2025, its largest moves.
• Castle Biosciences' Treasury Shares stood at $196033.0 in 2022, then changed by 0.0% to $196033.0 in 2023, then soared by 1530.45% to $3.2 million in 2024, then plunged by 89.05% to $350144.0 in 2025, then rose by 23.89% to $433784.0 in 2026.
• The last three Treasury Shares figures came in at $433784.0 (Q1 2026), $350144.0 (Q4 2025), and $3.9 million (Q3 2025), per Business Quant data.